Armando G. Gabrielli

Via Tronto
Ancona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 164 publications

Hierarchies of resistance to DNA damage response inhibitors: from pathway restoration to replication stress tolerance.

Hierarchies of resistance to DNA damage response inhibitors: from pathway restoration to replication stress tolerance.

Journal: Experimental hematology & oncology

Published: February 26, 2026

Role of hypertrophic adipocytes, collagen VI, and CD38 in adipose tissue fibrosis in obesity.

Role of hypertrophic adipocytes, collagen VI, and CD38 in adipose tissue fibrosis in obesity.

Journal: Scientific reports

Published: January 20, 2026

Guidance for the management of SARD-ILDs in clinical practice-impact of the ERS/EULAR recommendations.

Guidance for the management of SARD-ILDs in clinical practice-impact of the ERS/EULAR recommendations.

Journal: Annals of the rheumatic diseases

Published: October 06, 2025

Publisher Correction: An international perspective on the future of systemic sclerosis research.

Publisher Correction: An international perspective on the future of systemic sclerosis research.

Journal: Nature reviews. Rheumatology

Published: March 03, 2025

An international perspective on the future of systemic sclerosis research.

An international perspective on the future of systemic sclerosis research.

Journal: Nature reviews. Rheumatology

Published: December 20, 2024

A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.

A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.

Journal: Rheumatology (Oxford, England)

Published: October 22, 2024

EULAR recommendations for the treatment of systemic sclerosis: 2023 update.

EULAR recommendations for the treatment of systemic sclerosis: 2023 update.

Journal: Annals of the rheumatic diseases

Published: July 16, 2024

Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort.

Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort.

Journal: Swiss medical weekly

Published: April 05, 2024

Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics.

Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics.

Journal: Circulation research

Published: March 05, 2024

Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis.

Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis.

Journal: Arthritis research & therapy

Published: March 04, 2024

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 03, 2024

The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database.

The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database.

Journal: Diagnostics (Basel, Switzerland)

Published: December 04, 2023

Showing 1-12 of 164

Last Updated: 09/26/2026